COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,804 Articles (22,527 medRxiv, 8,277 bioRxiv)

Most recent first Previous |  Page 2368: Articles 23671-23680  | Next

The basic reproduction number of SARS-CoV-2: a scoping review of available evidence
Barber, A., Griffin, J. M., Casey, M., Collins, A., Lane, E. A., Ten Bosch, Q., De Jong, M., Mc Evoy, D., Byrne, A. W., McAloon, C. G., Butler, F., Hunt, K., More, S. J.
10.1101/2020.07.28.20163535 — Posted: 2020-07-30
Performance of Abbott Architect, Ortho Vitros, and Euroimmun Assays in Detecting Prior SARS-CoV-2 Infection
Mahajan, S., Redlich, C. A., Wisnewski, A. V., Fazen, L. E., Rao, L. V., Kuppusamy, K., Ko, A. I., Krumholz, H. M.
10.1101/2020.07.29.20164343 — Posted: 2020-07-30
Mechanistic modelling of coronavirus infections and the impact of confined neighbourhoods on a short time scale
Ahmed, D. A., Ansari, A. R., Imran, M., Dingle, K., Ahmed, N., Bonsall, M. A.
10.1101/2020.07.28.20163634 — Posted: 2020-07-30
Transmission of SARS-CoV-2 following exposure in school settings: experience from two Helsinki area exposure incidents.
Dub, T., Erra, E., Hagberg, L., Sarvikivi, E., Virta, C., Jarvinen, A., Osterlund, P., Ikonen, N., Haveri, A., Melin, M., Lukkarinen, T. J., Nohynek, H.
10.1101/2020.07.20.20156018 — Posted: 2020-07-30
Quality controlled SARS-CoV-2 duplex procedure to reduce time and scarce molecular biology diagnosis reagents
Collin, A., Chaboteaux, C., Fontaine, V., Lefevre, P.
10.1101/2020.07.28.20154153 — Posted: 2020-07-30
A Non-Adaptive Combinatorial Group Testing Strategy to Facilitate Healthcare Worker Screening During the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Outbreak
McDermott, J. H., Stoddard, D., Woolf, P., Ellingford, J. M., Gokhale, D., Taylor, A., Demain, L. A., Newman, W. G., Black, G.
10.1101/2020.07.21.20157677 — Posted: 2020-07-30
Model stability of COVID-19 mortality prediction with biomarkers
Huang, C., Long, X., Zhan, Z., van den Heuvel, E.
10.1101/2020.07.29.20161323 — Posted: 2020-07-30
Evidence favouring the efficacy of convalescent plasma for COVID-19 therapy
Joyner, M. J., Klassen, S. A., Senefeld, J., Johnson, P. W., Carter, R. E., Wiggins, C. C., Shoham, S., Grossman, B. J., Henderson, J. P., Musser, J. M., Salazar, E., Hartman, W. R., Bouvier, N. M., Liu, S. T. H., Pirofski, L.-a., Baker, S. E., Van Helmond, N., Wright, R. S., Fairweather, D., Bruno, K. A., Paneth, N. S., Casadevall, A.
10.1101/2020.07.29.20162917 — Posted: 2020-07-30 Discussion: Onsite | Offsite
Evaluation of a novel community-based COVID-19 'Test-to-Care model' for low-income populations
Kerkhoff, A. D., Sachdev, D., Mizany, S., Rojas, S., Gandhi, M., Peng, J., Black, D., Jones, D., Rojas, S., Jacobo, J., Tulier-Laiwa, V., Petersen, M., Martinez, J., Chamie, G., Havlir, D. V., Marquez, C.
10.1101/2020.07.28.20161646 — Posted: 2020-07-30
Unemployment insurance and food insecurity among people who lost employment in the wake of COVID-19
Raifman, J., Bor, J., Venkataramani, A.
10.1101/2020.07.28.20163618 — Posted: 2020-07-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).